Waters Corporation Investor Presentation — May 2022

Document content

May 19, 20222022 Analyst & Investor Day1 ©2022 Waters Corporation

Head of Investor Relations

2 ©2022 Waters Corporation

This presentation contains forward- looking statements regarding future results and events, including financial and operational guidance and projected

estimates. For this purpose, any statements that are not statements of historical fact may be deemed forward- looking statements. Words such as “may,”

“will,” “expect,” “plan,” “anticipate,” “estimate,” “intend” , “project” and similar expressions (as well as other words or expr essions referencing future events,

conditions or circumstances) are intended to identify forward- looking statements. Forward- looking statements are based on current expectations and

assumptions and currently available data and are neither predictions nor guarantees of future events or performance, market grow th, success of our

products, and customer trends. You should not place undue reliance on forward- looking statements, which speak only as of the date hereof and should not

be relied upon as representing the Company’s estimates or views as of any date subsequent to the date of this presentation. We do not undertake to

update or revise any forward- looking statements after they are made, whether as a result of new information, future events, or otherwise, except as required

by applicable law. Please also note that the guidance provided herein with respect to 2022, which was first publicly disclosed on May 3, 2022, is included

for reference purposes, only, and has not been updated or reaffirmed as of this or any other date. The Company’s actual futur e results may differ

significantly from the results discussed in the forward- looking statements within this presentation for a variety of reasons, including and without limitation,

risks related to the effects of the ongoing COVID -19 pandemic on our business, financial condition, results of operations and pr ospects, including: portions

of our global workforce being unable to work fully and/or effectively due to working remotely, illness, quarantines, government actions, facility closures or

other reasons related to the pandemic, increased risks of cyber -attacks resulting from our temporary remote working model, disruptions in our

manufacturing capabilities or to our supply chain, volatility and uncertainty in global capital markets limiting our ability to access capital, customers being

unable to make timely payments for purchases and volatility in demand for our products; foreign exchange rate fluctuations potentially affecting translation of the Company’s future non- U.S. operating results; fluctuations in expenditures by the Company’s customers, in particular large pharmaceutical